Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- NIBIO Completes Development of Prototype Adjuvant Database
January 22, 2015
- PAFSC’s Second Committee on Drugs Recommends Approval for Eisai’s Lenvatinib
January 22, 2015
- R&D Tax Credit Revamp (2): No Deadline Set, yet Revision Could Come Up for Debate towards FY2017
January 21, 2015
- Health Ministry Reveals Guidelines on Research Misconduct
January 20, 2015
- R&D Tax Credit Revamp (1): New Scheme for Open Innovation Research Significant in 3 Ways
January 20, 2015
- Consumer Affairs Agency to Begin Study on Child-Resistant PTP Sheets
January 20, 2015
- PAFSC 1st Committee to Discuss Takeda’s Once-Weekly DPP-4 Inhibitor on Jan. 30
January 20, 2015
- NIBIO to Launch Project to Collate Compound Libraries, Academic Seeds
January 19, 2015
- AMED Chief-to-Be Vows to Overhaul Siloed Research Grants
January 19, 2015
- PMDA Head Expresses Full Support for AMED
January 19, 2015
- 112.8 Billion Yen Allotted to Intractable Disease Measures
January 19, 2015
- 65 Institutions to Treat Post-HPV Vaccine Adverse Reactions
January 16, 2015
- MHLW to Reorganize Health Service Bureau in FY2015
January 16, 2015
- LDP’s Takemi Says NHI Prices Will Probably Be Cut for 3 Years in a Row
January 16, 2015
- MHLW Approves Plan to Include Hepatitis B Vaccines in Public Vaccination Programs
January 16, 2015
- 1.9 Billion Yen Allocated to Speed Up Regulatory Reviews
January 15, 2015
- 124.8 Billion Yen Earmarked in FY2015 Budget for AMED
January 15, 2015
- AJMC to Announce Guidelines for Investigator-Led Clinical Trials Next Month
January 15, 2015
- Japan Govt OKs FY2015 Tax Reform Plan
January 15, 2015
- Editor’s Pick: Five Healthcare News Headlines for Dec. 29 - Jan. 11
January 14, 2015
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…